Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 3/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 2/20 | 0.33 |
| ▸ | EGLN2 | Q96KS0 | 3/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | SMO | Q99835 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758598 | 0.90 | SMO (0.35) | KCNH2CYP11B1CYP11B2ELANEKDM1A | |
| SCHEMBL21758191 | 0.90 | IDO1 (0.37) | ELANEPDE4AIDO1SMOTNKS2 | |
| SCHEMBL21758232 | 0.87 | PTGER4 (0.37) | KCNH2CYP11B1CYP11B2ELANEPDE4A | |
| SCHEMBL21758728 | 0.87 | GRM5 (0.35) | CYP11B1CYP11B2ELANEPDE4AEGLN2 | |
| SCHEMBL21758597 | 0.87 | PTGER4 (0.36) | KCNH2CYP11B1CYP11B2ELANEPDE4A | |
| SCHEMBL21758233 | 0.86 | PTGER4 (0.37) | ELANEIDO1SMOTNKS2DDB1 | |
| SCHEMBL21758187 | 0.86 | IDO1 (0.37) | ELANEPDE4AIDO1SMOTNKS2 | |
| SCHEMBL21758512 | 0.86 | STS (0.34) | KCNH2CYP11B2ELANEDDB1CRBN | |
| SCHEMBL21758511 | 0.85 | MAP4K4 (0.36) | CYP11B1CYP11B2DDB1CRBNMAPKAPK2 | |
| SCHEMBL21758230 | 0.84 | DDB1 (0.40) | CYP11B2ELANEPDE4ASMODDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | KCNH2 1742/4885CYP11B1 1224/4885CYP11B2 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.